Generic Diabetes Medication Shows Bioequivalence to Janumet XR

AI-generated NewsSnap summary based on source reporting.
Published: 2026-10-14
Category: health
Source: GeneOnline News
Original source

A clinical trial confirmed a new generic sitagliptin/metformin extended-release tablet is bioequivalent to Janumet XR in healthy Chinese subjects. The study, published by GeneOnline News, showed similar pharmacokinetic profiles and safety, potentially increasing access to a more affordable treatment option for type 2 diabetes.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai